Results 301 to 310 of about 5,024,684 (342)
Some of the next articles are maybe not open access.
Plant inhibitors of proteolytic enzymes
Food / Nahrung, 1984AbstractThe presence of inhibitors of proteinases was stated in many species of plants. There are macropeptides of the molecular weight ranging from 3700 to 8000, often bound to carbohydrates. Potential sources of inhibitors of proteinases are legumes, cereals, potatoes and also some fruits. They are characterized by different activity. „Single‐headed”︁
B. Romanowska, G. Mossor, J. Skupin
openaire +3 more sources
Interactions of enzymes and inhibitors
Journal of Chemical Education, 1967Examines the kinetics and interactions of enzymes and inhibitors and considers specifically lactic dehydrogenase, dihydrofolic reductase, thymidine phosphorylate, guanase, and xanthine oxidase.
openaire +2 more sources
Polyoxometalates as Versatile Enzyme Inhibitors
, 2013Polyoxometalates (POMs) are inorganic cluster compounds that have been shown to possess a number of pharmacological properties, including antidiabetic, antibacterial, antiprotozoal, antiviral and anticancer activities. Their molecular mechanism of action
H. Stephan +3 more
semanticscholar +1 more source
Angiotensin-converting enzyme inhibitors
2001Publisher Summary Angiotensin-converting enzyme (ACE) inhibitors were first studied clinically in the 1970s. ACE inhibitors were discovered by taking advantage of previous basic research on the physiology of sodium, potassium, and water homeostasis and blood pressure regulation, in a reciprocal way ACE have also advanced research in this field, and ...
Arthur A. Patchett, Joël Ménard
openaire +3 more sources
1990
Converting enzyme (CE; EC 3.4.15.1) is an exopeptidase which catalyzes the hydrolytic removal of carboxyterminal dipeptide residues from polypeptide substrates. This enzyme is involved in blood pressure regulation in a unique manner. First, it catalyzes the conversion of the inactive decapeptide angiotensin I (ANG I) to the octapeptide, angiotensin II (
M.-G. Gruber, T. Unger, P. Gohlke
openaire +2 more sources
Converting enzyme (CE; EC 3.4.15.1) is an exopeptidase which catalyzes the hydrolytic removal of carboxyterminal dipeptide residues from polypeptide substrates. This enzyme is involved in blood pressure regulation in a unique manner. First, it catalyzes the conversion of the inactive decapeptide angiotensin I (ANG I) to the octapeptide, angiotensin II (
M.-G. Gruber, T. Unger, P. Gohlke
openaire +2 more sources
angiotensin converting enzyme inhibitors
2012More than 30 years since their discovery, angiotensin-converting enzyme (ACE) inhibitors still represent one of the most commonly prescribed medications for treating hypertension and one of the favored first-line agents, particularly in the presence of high-risk conditions, such as diabetes.
GENTILE, GIORGIO +4 more
openaire +4 more sources
Food Chemistry, 1981
Abstract The range of proteins from plants which form reversible stoichiometric protein-protein complexes with enzymes, thus inhibiting their catalytic functions, is surveyed. Details of the biochemistry of the proteinase- and α-amylase inhibitors found in the important food crops such as the cereals, legumes and potatoes are given.
openaire +2 more sources
Abstract The range of proteins from plants which form reversible stoichiometric protein-protein complexes with enzymes, thus inhibiting their catalytic functions, is surveyed. Details of the biochemistry of the proteinase- and α-amylase inhibitors found in the important food crops such as the cereals, legumes and potatoes are given.
openaire +2 more sources
2010
Synthetic biomimetic compounds play crucial roles in virtually all aspects of biology and medicine. Their continual development contributes towards understanding and manipulating the normal action of enzymes and other proteins as well as in the development of new drugs.
openaire +2 more sources
Synthetic biomimetic compounds play crucial roles in virtually all aspects of biology and medicine. Their continual development contributes towards understanding and manipulating the normal action of enzymes and other proteins as well as in the development of new drugs.
openaire +2 more sources
Studies on Antibiotics and Enzyme Inhibitors
Clinical Infectious Diseases, 1987I have been studying antibiotics since 1944. In 1951, pathogenic bacteria resistant to antibiotic drugs had not yet appeared, and it seemed that effective chemotherapy for all bacterial diseases except tuberculosis was a fait accompli. Therefore, I initiated screening for antibiotics active against tumors.
openaire +3 more sources